-
ICGC PCAWG Dataset: RECA-EU_PCAWG_RNA-Seq_TopHat2
Dataset
EGAD00001003559
-
ICGC PCAWG Dataset: MALY-DE_PCAWG_RNA-Seq_Star
Dataset
EGAD00001003560
-
ICGC PCAWG Dataset: MALY-DE_PCAWG_RNA-Seq_TopHat2
Dataset
EGAD00001003561
-
Fecal WMS UC metadata
Dataset
EGAD00001008820
-
Fecal 16S HV metadata
Dataset
EGAD00001008821
-
Fecal 16S UC metadata
Dataset
EGAD00001008822
-
A108757B
Dataset
EGAD00001007086
-
scMultiome analysis of human tongue cancer organoids
Study
JGAS000606
-
Whole exome sequencing of 69 trios with bipolar disorder
Study
JGAS000273
-
WES - Characterization of a Breast Patient-derived Tumor Organoid biobank from an underserved population of patients.
Study
EGAS50000000684
-
Cohort B germline exome sequencing
Study
EGAS50000000951
-
Whole-genome sequencing of high-retrotransposition rate tumours
Study
EGAS50000000414
-
BAM files of mapped reads from scDNAsequencing
Study
EGAS50000000019
-
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient
Study
EGAS50000000102
-
WHOLE GENOME SEQUENCING OF CLEAR CELL RENAL CELL CARCINOMA IN VHL PATIENT
Study
EGAS50000000295
-
Bulk RNA-seq data of isogenic wild-type RPE1
Dataset
EGAD50000001544
-
DNA sequencing of sgRNAs in CRISPR-Cas9 screening and RNA sequencing of SF3B4-overexpressing liver organoids
Dataset
EGAD50000001240
-
Mitochondrial DNA sequencing of single muscle fibers in Parkinson's disease patients
Dataset
EGAD50000000946
-
WGS from melanoma patient tumor/normal pairs and longitudinal panel-based cfDNA sequencing data
Dataset
EGAD50000000785
-
RNA sequencing of OM-ALI cultures derived from control and AD individuals exposed to SARS-CoV-2
Dataset
EGAD50000000598
-
Genomic profiling of patient-derived xenografts and organoids in prostate cancer
Dataset
EGAD00001006403
-
Resistance to anti-BCMA T-cell-redirecting therapy
Study
EGAS50000001817
-
RNA-sequencing of Non-muscle Invasive Bladder cancer (NMIBC)
Study
EGAS00001004358
-
AML clonal phylogeny
Study
EGAS00001001779
-
G-SAM: Transcriptional Evolution of Glioblastomas Treated With Standard of Care
Study
EGAS00001005436